ライフサイエンスコーパス: phacoemulsification

1 old (3-fold for M-SICS and nearly 6-fold for phacoemulsification).

2 he 40 777 private surgeries (21% M-SICS; 79% phacoemulsification).

3 and at least 5 visits in the year following phacoemulsification.

4 cause comparable ECL to that of conventional phacoemulsification.

5 ult in similar ECL rates to that of standard phacoemulsification.

6 CT) after intraoperative complication during phacoemulsification.

7 at each clinic visit prior to and following phacoemulsification.

8 torsional (n = 26) or longitudinal (n = 26) phacoemulsification.

9 ancement in the field since the inception of phacoemulsification.

10 bility significantly improves after cataract phacoemulsification.

11 low for the enhancement of partial occlusion phacoemulsification.

12 shown to yield similar surgical outcomes as phacoemulsification.

13 influence the future quality of training in phacoemulsification.

14 ique advantages over conventional ultrasound phacoemulsification.

15 s chatter, and improved followability during phacoemulsification.

16 psular cataract extraction to small-incision phacoemulsification.

17 ained within 1 month of performing the first phacoemulsification.

18 nd long eyes using ultrasound biometry after phacoemulsification.

19 ibiotics should be considered for M-SICS and phacoemulsification.

20 ome, Italy) in patients undergoing bilateral phacoemulsification.

21 Three patients had an uncomplicated phacoemulsification.

22 .6 mm (long AL) that underwent uncomplicated phacoemulsification.

23 patients with a history of CME who underwent phacoemulsification.

24 (Microsurgical Technology Inc) were used for phacoemulsification.

25 Intervention was cataract surgery by phacoemulsification.

26 ce or less ECL with FLACS than with standard phacoemulsification 1-3 months after surgery.

27 After phacoemulsification, 2 capsulotomy edge retractors attac

28 he most frequent surgical interventions were phacoemulsification (20.8%) and pars plana vitrectomy (1

29 Ruptures most frequently occurred during phacoemulsification (59.6%) and irrigation and aspiratio

30 roportion from extracapsular extraction than phacoemulsification (7.9% vs. 0.15%; P < 0.0001).

31 ter (>/=20/40) was achieved in 68% following phacoemulsification, 72% following extracapsular catarac

32 ty clinic based glaucoma patients undergoing phacoemulsification alone, with at least 3 visits in the

33 combined surgery, the comparison of combined phacoemulsification and combined standard extracapsular

34 to those obtained with conventional coaxial phacoemulsification and established intraocular lenses.

35 Two surgical techniques were evaluated: phacoemulsification and extracapsular extraction.

36 rowth factor (VEGF) injections who underwent phacoemulsification and had a postsurgery follow-up of 6

37 gle procedure (n = 9) or in combination with phacoemulsification and implantation of a posterior cham

38 cts were recruited and randomized to receive phacoemulsification and implantation of either the AcryS

39 Patients underwent phacoemulsification and implantation of the AcrySof SA60

40 mporal clear corneal incisions of uneventful phacoemulsification and in-the-bag intraocular lens impl

41 The procedure was completed by phacoemulsification and insertion of an intraocular lens

42 The procedure was completed by phacoemulsification and insertion of an intraocular lens

43 osthetic iris implantation was combined with phacoemulsification and intraocular lens (IOL) implantat

44 Twenty-one eyes of 21 patients undergoing phacoemulsification and IOL implantation after myopic la

45 omy and silicone oil tamponade combined with phacoemulsification and IOL implantation for recurrent i

46 Eyes in this series underwent phacoemulsification and IOL implantation with local anes

47 ompared for all eyes and separately for both phacoemulsification and M-SICS, and for the eyes complic

48 Both phacoemulsification and manual small incision extracapsu

49 Both phacoemulsification and MSICS led to significant and sim

50 One patient underwent combined phacoemulsification and pars plana vitrectomy for retina

51 nts with diabetes, combining vitrectomy with phacoemulsification and posterior capsulectomy allows pa

52 Combining pars plana vitrectomy with phacoemulsification and posterior capsulectomy now has t

53 dest, long-lasting decrease in IOP following phacoemulsification and posterior chamber intraocular le

54 rocedures were performed in combination with phacoemulsification and posterior chamber intraocular le

55 meral (IC) moxifloxacin prophylaxis for both phacoemulsification and sutureless, manual small-incisio

56 Phacoemulsification and the contemporary implantation of

57 derwent trabeculectomy (85 eyes) or combined phacoemulsification and trabeculectomy (10 eyes) and wer

58 Combined phacoemulsification and trabeculectomy has become a comm

59 nt at the time of trabeculectomy or combined phacoemulsification and trabeculectomy is associated wit

60 Current techniques using small-incision phacoemulsification and trabeculectomy with antimetaboli

61 acy and safety of trabeculectomy or combined phacoemulsification and trabeculectomy with mitomycin-C

62 With the advent of small-incision phacoemulsification and trabeculectomy with releasable s

63 In combined phacoemulsification and trabeculectomy, a one-site appro

64 loying antimetabolites routinely in combined phacoemulsification and trabeculectomy.

65 d to the point that Kelman's introduction of phacoemulsification and use of intraocular lenses (IOLs)

66 Patients underwent lens phacoemulsification and were implanted bilaterally with

67 nduced clinically during cataract removal by phacoemulsification, and may be one mechanism responsibl

68 , ocular pharmacology, viscoelastic devices, phacoemulsification, and the most recent advancement, in

69 separate procedures: pars plana vitrectomy, phacoemulsification, and YAG capsulotomy into one proced

70 ive cataract surgery approaches suggests the phacoemulsification approach is preferable.

71 visualization of the anterior capsule during phacoemulsification are compared.

72 prior incisional glaucoma surgery undergoing phacoemulsification by a single surgeon between January

73 lterations to normal positioning, successful phacoemulsification can be executed.

74 that purport to offer simpler techniques for phacoemulsification, capsulotomy, nucleus expression, an

75 t participation added $105.40 to the average phacoemulsification case.

76 Prospective assessment of consecutive phacoemulsification cases (N = 500) enabled calculation

77 0, there were 887 capsule ruptures in 48 377 phacoemulsification cases (rate 1.8%).

78 udy of consecutive RP patients who underwent phacoemulsification cataract extraction and intraocular

79 tment with the femtosecond laser followed by phacoemulsification cataract extraction and IOL insertio

80 Controls underwent phacoemulsification cataract extraction plus insertion o

81 undergoing separate first eye and second eye phacoemulsification cataract surgeries at 5 veterans aff

82 ool for the complete four main procedures of phacoemulsification cataract surgery (rho < 0.05), indic

83 ied acute POE occurring within 6 weeks after phacoemulsification cataract surgery and the use of intr

84 Occlusion break surge during phacoemulsification cataract surgery can lead to potenti

85 l patients underwent uncomplicated first-eye phacoemulsification cataract surgery from 2000 through 2

86 us to observe a decrease in acute POE after phacoemulsification cataract surgery from 2005 to 2014.

87 ical data of 500 consecutive cases, prior to phacoemulsification cataract surgery performed between A

88 Phacoemulsification cataract surgery performed in MPRs o

89 perform the virtual surgery of the four main phacoemulsification cataract surgery procedures - 1) cor

90 jective of this study was to conduct virtual phacoemulsification cataract surgery to compare performa

91 icipant was required to perform the complete phacoemulsification cataract surgery using the simulator

92 consecutive small eyes undergoing uneventful phacoemulsification cataract surgery with a single highl

93 efractive results compared with conventional phacoemulsification cataract surgery, even during the in

94 dophakic macular edema occurs commonly after phacoemulsification cataract surgery, even in the absenc

95 he PPC by 2 surgeons, followed up by routine phacoemulsification cataract surgery, was undertaken.

96 occlusion break surge may increase safety of phacoemulsification cataract surgery.

97 stically equivalent to those of conventional phacoemulsification cataract surgery.

98 omparisons to outcomes found in conventional phacoemulsification cataract surgery.

99 ressure (IOP) 21-33 mmHg and were undergoing phacoemulsification cataract surgery.

100 phakic cystoid macular edema is common after phacoemulsification cataract surgery.

101 371 242 eyes in 3 983 525 patients underwent phacoemulsification cataract surgery.

102 or chamber following otherwise uncomplicated phacoemulsification cataract surgery.

103 cataract that underwent combined DSAEK with phacoemulsification cataract surgery.

104 Phacoemulsification causes a significant elevation of IO

105 groups: group A included eyes that underwent phacoemulsification combined with 25G HS-PPV (348 eyes),

106 To stratify the outcomes of phacoemulsification combined with trabectome surgery usi

107 with visually significant cataract that had phacoemulsification combined with trabectome surgery.

108 lens (SPA-IOL) in the ciliary sulcus during phacoemulsification complicated with posterior capsule t

109 The incidence of acute POE after phacoemulsification decreased from 0.145% to 0.053% duri

110 OP reduction was observed in eyes undergoing phacoemulsification (DeltaIOP = 2.7+/-2.9 mmHg) and MSIC

111 Training in phacoemulsification during residency is one of the most

112 Torsional phacoemulsification effectively reduces ultrasonography

113 al power becomes more critical at increasing phacoemulsification efficiencies at torsional amplitudes

114 laucoma patients with open angles undergoing phacoemulsification experienced an increase in IOP or re

115 For the 194 252 phacoemulsification eyes, the endophthalmitis rate was 0

116 algam of new technologists which may include phacoemulsification, foldable intraocular lenses and, in

117 All patients underwent phacoemulsification followed by IOL implantation in the

118 d to topical steroid use after uncomplicated phacoemulsification for the prevention of pseudophakic c

119 and silicone oil instillation combined with phacoemulsification for tractive retinal detachment and

120 Phacoemulsification for visually significant cataract an

121 these new glaucoma procedures combined with phacoemulsification generally include retrospective case

122 Ninety-four patients scheduled for bilateral phacoemulsification had an SE-PMMA IOL implanted in 1 ey

123 y was performed alone or in combination with phacoemulsification in eyes with cataract.

124 s prolapse occurred, IPH was injected during phacoemulsification in group 2.

125 of teaching experienced surgeons to perform phacoemulsification in India, a cataract-endemic area.

126 im of the study is to compare the outcome of phacoemulsification in patients with and without pseudoe

127 owing, and prolapse was noted during routine phacoemulsification in patients with current or previous

128 reased risk for corneal decompensation after phacoemulsification in patients with FED.

129 dissipated energy compared with longitudinal phacoemulsification in patients with FED.

130 Phacoemulsification in presence of pseudoexfoliation nec

131 s of new surgeries that can be combined with phacoemulsification in the management of cataract and gl

132 The filtering blebs after phacoemulsification in the study group were characterize

133 ct surgery, and, while not a replacement for phacoemulsification in Western countries, should be part

134 Phacoemulsification incision placement on the steep corn

135 Three MET interventions related to the phacoemulsification/intraocular lens pathway occurred in

136 Surgery included phacoemulsification, IOL (Acrysof SN60AT; Alcon) implant

137 We aim to investigate whether phacoemulsification is associated with optic disc hemorr

138 Phacoemulsification is made easier and safer with phaco

139 Trabeculectomy within 6 to 24 months after phacoemulsification is rare in such patients.

140 Phacoemulsification is the preferred technique for catar

141 A Signature (Abbott Medical Optics, Inc) phacoemulsification machine was used in peristaltic and

142 Cataract surgery at earlier stages by phacoemulsification may be more beneficial than undergoi

143 Although it is well recognized that phacoemulsification may result in a modest sustained red

144 atients subjected to both trabeculectomy and phacoemulsification, mean IOP was significantly higher t

145 (control) or supraciliary microstenting with phacoemulsification (microstent) groups (1:3 ratio).

146 uded ocular surgery other than clear corneal phacoemulsification, myopia >6 diopters, contact lens us

147 se posterior capsule rupture than ultrasonic phacoemulsification needles, and is more efficient than

148 Phacoemulsification of uncomplicated cataracts with intr

149 bined with trabeculectomy, and the effect of phacoemulsification on intraocular pressure in patients

150 subjects were intraoperatively randomized to phacoemulsification only (control) or supraciliary micro

151 complete cataract removal was performed with phacoemulsification only, using pulsed ultrasound energy

152 n is associated with significantly increased phacoemulsification operative times and costs during the

153 Surgery was performed using phacoemulsification or manual small-incision cataract su

154 Eyes underwent phacoemulsification or MSICS after a 1:1 randomization a

155 higher risk of complications as compared to phacoemulsification (OR = 5.95, 95% CI = 1.49-23.73, P =

156 The improvements of phacoemulsification over extracapsular surgery have natu

157 ted with the development of lens opacity and phacoemulsification (P = .005 and .008, respectively).

158 he DEX implant greater than 4 weeks prior to phacoemulsification (P = .005).

159 neal incision (CI), 2) capsulorhexis (C), 3) phacoemulsification (P), and 4) intraocular lens implant

160 ng a complication decreased as the number of phacoemulsifications performed increased.

161 ining glaucoma surgery with minimal invasive phacoemulsification (phaco) is a considerable option to

162 erformed successfully using all of the major phacoemulsification platforms.

163 Forty eyes underwent combined phacoemulsification, PPV, ILM peeling, and intraocular l

164 Phacoemulsification procedures conducted by 7 surgeons w

165 udy included all patients undergoing routine phacoemulsification procedures with implantation of the

166 patients; follow-up, 17 months) showed that phacoemulsification reduced IOP by 13% and glaucoma medi

167 , 132 patients; follow-up, 34 months) showed phacoemulsification reduced IOP by 20% and glaucoma medi

168 , 495 patients; follow-up, 16 months) showed phacoemulsification reduced IOP by 30% and glaucoma medi

169 Phacoemulsification resulted in a small average decrease

170 Cataract surgery by phacoemulsification results in large intraocular pressur

171 ncremental improvements have made ultrasonic phacoemulsification safer to the posterior capsule and l

172 Operating room records of all phacoemulsification surgeries performed at a single acad

173 Phacoemulsification surgeries took an average of 12 minu

174 utive patients, aged >/=64 years, undergoing phacoemulsification surgery at Westmead Hospital were fo

175 ecutive patients aged >/=64 years undergoing phacoemulsification surgery at Westmead Hospital were re

176 not support the generalized conclusion that phacoemulsification surgery causes progression of retino

177 lic object 40 years ago and an uncomplicated phacoemulsification surgery in the same eye 2 years earl

178 Phacoemulsification surgery may aggravate the signs and

179 fect of preoperative risk stratification for phacoemulsification surgery on intraoperative complicati

180 o evaluate the visual outcomes and effect of phacoemulsification surgery on the progression of neovas

181 Phacoemulsification surgery significantly improved visio

182 ere visual impairment in older patients with phacoemulsification surgery was associated with a lower

183 eye syndrome and cataract, who had undergone phacoemulsification surgery were enrolled in this study.

184 mild PCO occurred in one-third of eyes after phacoemulsification surgery.

185 n and customization of surgical technique in phacoemulsification surgery.

186 valuate the course of dry eye syndrome after phacoemulsification surgery.

187 ld instrument that can be used in the normal phacoemulsification surgical sequence.

188 for cataracts by 1 of 4 surgical approaches (phacoemulsification, sutured manual extracapsular catara

189 R) Vision System, the WhiteStar Signature(R) Phacoemulsification System, and the Centurion(R) Vision

190 break surge and vacuum rise time of current phacoemulsification systems used in cataract surgery.

191 Continual advances in phacoemulsification technology and adjunctive surgical d

192 surgical technique that continues to grow as phacoemulsification technology and intraocular-lens desi

193 tion techniques using microincisions and new phacoemulsification technology will enhance the safety o

194 ny physicians now feel that small incisions, phacoemulsification technology, and intraocular lenses (

195 viscoelastic materials and modifications in phacoemulsification technology.

196 e achieved with the most current advances in phacoemulsification technology.

197 ssists in understanding the advances made in phacoemulsification technology.

198 Lower risk of hypotony with phacoemulsification than with alternative cataract surge

199 After phacoemulsification the prevalence of some degree of PVD

200 Phacoemulsification, the type of cataract surgery associ

201 osecond lens fragmentation method, effective phacoemulsification time (EPT), intraoperative complicat

202 nce in favor of FLACS over MCS for effective phacoemulsification time (WMD, -3.03; 95% CI, -3.80 to -

203 Effective phacoemulsification time and endothelial cell loss were

204 ith increasing preoperative PNS-P, effective phacoemulsification time increased in both groups; howev

205 Effective phacoemulsification time was reduced 28.6% within the fe

206 Overall mean effective phacoemulsification time was significantly lower in grou

207 Effective phacoemulsification time was significantly lower in grou

208 e lens position as well as reduced effective phacoemulsification time with the use of FSL compared wi

209 ults in a significant reduction in effective phacoemulsification time, including the possibility of 0

210 allows a significant reduction in effective phacoemulsification time, which correlates positively wi

211 Mean surgical and phacoemulsification times were 15.8+/-3.7 minutes and 2.

212 72.8% reduction was achieved with a 20-gauge phacoemulsification tip.

213 The techniques of combined phacoemulsification-trabeculectomy are under continual d

214 us recent aspects of the combined procedure, phacoemulsification-trabeculectomy, antimetabolites, res

215 s trabeculectomy as well as newer studies on phacoemulsification-trabeculectomy.

216 To examine the current status of phacoemulsification training and the factors that will i

217 The quality of phacoemulsification training in the US is currently thre

218 The impending decline in quality of phacoemulsification training in US residencies can be pr

219 Phacoemulsification typically results in small, moderate

220 red cells were treated for 60 seconds with a phacoemulsification ultrasound probe set to a power of 7

221 a, often decreases after cataract removal by phacoemulsification ultrasound.

222 xpression was increased after treatment with phacoemulsification ultrasound.

223 Cataract surgery was performed by phacoemulsification under topical anesthesia.

224 iples guiding recent technologic upgrades in phacoemulsification units will help the surgeon to maxim

225 ere randomly assigned to 2.2 mm microcoaxial phacoemulsification using the OZil Intelligent Phaco tor

226 In the study group, planned phacoemulsification was converted to manual extraction i

227 Lens cube phacoemulsification was done using OZil IP at 60%, 80%,

228 Phacoemulsification was performed by 2 experienced surge

229 Phacoemulsification was performed in 5 eyes (4.9%; 95% C

230 Phacoemulsification was performed in 99.9% of cases, and

231 required long-term glaucoma medications when phacoemulsification was performed soon after medical red

232 Trabeculectomy after phacoemulsification was uncommon; the median rate report

233 enced surgeons (a total of 300 cases), using phacoemulsification were prospectively evaluated.

234 5 women, 45-66 years) who underwent cataract phacoemulsification were studied.

235 ot find an increase in ODH in the year after phacoemulsification when compared to the year prior to s

236 nt are well established tools for use during phacoemulsification when zonular instability is present.

237 Our study demonstrates that phacoemulsification whether done with a clear temporal o

238 ween the immediate 6 months before and after phacoemulsification, which was equal to 0.1667 injection

239 The combination of cataract or lens phacoemulsification with 25G HS-PPV for vitreomacular di

240 amination rate of 33.33% (n = 8) compared to phacoemulsification with a rate of 25% (n = 2) (RR = 1.3

241 erior group) including 50 patients underwent phacoemulsification with a superior corneal incision.

242 poral group) including 50 patients underwent phacoemulsification with a temporal corneal incision and

243 Several studies have reported that phacoemulsification with intraocular lens implantation a

244 ients with RP were categorized as having had phacoemulsification with intraocular lens implantation v

245 Phacoemulsification with intraocular lens implantation w

246 All patients underwent phacoemulsification with intraocular lens implantation.

247 EX 0.7 mg intravitreal implant and underwent phacoemulsification with intraocular lens placement.

248 The study compared eyes that underwent phacoemulsification with IOL implant at least 3 months p

249 Phacoemulsification with IOL implant, PPV with silicone

250 implantation and Group 2 patients underwent phacoemulsification with monofocal IOL implantation foll

251 l study including 12 patients, who underwent phacoemulsification with PCT and sulcus implantation of

252 ay be implanted in the ciliary sulcus during phacoemulsification with PCT rather than switching to an

253 n and preventing PCME in patients undergoing phacoemulsification with posterior chamber intraocular l

254 Phacoemulsification with posterior chamber intraocular l

255 im of the study was to analyse the effect of phacoemulsification with posterior chamber lens implanta

256 ccessful trabeculectomy with 5-Fluorouracil, phacoemulsification with posterior chamber lens implanta

257 ction in corneal endothelial cell loss after phacoemulsification with the use of viscoelastic materia

258 Group 1 patients underwent phacoemulsification with toric intraocular lens (IOL) im

259 All 5 eyes underwent phacoemulsification with use of iris retractors.

260 s that had been recorded 5 to 120 days after phacoemulsification with visual acuity 20/40 or worse an

261 manual extracapsular cataract extraction and phacoemulsification--with ECCE further separated into th

262 In the subset of eyes that underwent phacoemulsification within 4 weeks of the DEX implant (8